VCG
CHRS icon

Vantage Consulting Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Vantage Consulting Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,712
Closed -$65K – 380
2020
Q4 		$65K Buy
+3,712
New +$65K 0.01% 347